[Retracted] Steroid-Eluting Implants for Chronic Rhinosinusitis with nasal polyps: A Comparative Review of Propel and Sinuva for Post-Endoscopic sinus surgery management
Main Article Content
Authors
Dow University of Health Sciences, Karachi, Pakistan
Dow University of Health Sciences, Karachi, Pakistan
Dow University of Health Sciences, Karachi, Pakistan
Medical College, Aga Khan University, Stadium Road, Karachi 74800, Pakistan
Department of Otolaryngology-Head and Neck Surgery, Ruth Km Pfau Civil Hospital, Karachi, Pakistan
Abstract
RETRACTED ARTICLE
The Editorial Office of Health Nexus retracts the following article:
Siddiqui MK, Anzar M, Hasan A, Shahid AH, Hashmi SQ. Steroid-Eluting Implants for Chronic Rhinosinusitis with Nasal Polyps: A Comparative Review of Propel and Sinuva for Post-Endoscopic Sinus Surgery Management. Health Nexus. 2026;2:40–50. doi:10.63802/hn.V2.2026.154
Following a post-publication editorial review, serious concerns were identified regarding the accuracy, traceability, and reliability of the article’s reference list and the evidentiary support for several statements in the manuscript. The concerns included inaccurate bibliographic metadata, DOI-to-title mismatches, incomplete or insufficient product-information citations, and inconsistencies between the reference list, the text, and the summary tables.
Because this article is a narrative review, the cited literature forms the foundation of the article’s conclusions. The extent and pattern of the identified issues affect the transparency, verifiability, and reliability of the scholarly record. After further editorial assessment, the Editorial Office determined that a post-publication correction would not be sufficient to resolve these concerns, as the necessary changes would require substantial reconstruction of the article’s evidence base rather than correction of discrete errors.
The authors acknowledged the concerns raised by the Editorial Office and requested an opportunity to correct the article. After careful consideration, the Editorial Office maintained the decision to retract the article.
This retraction is issued in accordance with the journal’s publication ethics policy and is intended to correct the scholarly record. It does not, by itself, constitute a finding of research misconduct.
The original article will remain available online to preserve the scholarly record and will be clearly marked as retracted.
Author response: The authors acknowledged the concerns and requested an opportunity to correct the article. After further editorial assessment, the Editorial Office maintained the decision to retract the article.
Editorial Office of Health Nexus
Health Nexus
Panorama Scholarly Group
Date of Retraction: 3 June 2026
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright remains with the author(s). All articles are published under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license permits use, sharing, adaptation, distribution, and reproduction in any medium or format, provided that appropriate credit is given to the original author(s) and the source, a link to the license is provided, and any changes are indicated.
How to Cite
References
Suh JD, Kennedy DW. Treatment options for chronic rhinosinusitis. Proc Am Thorac Soc. 2011;8(1):132–140. doi:10.1513/pats.201006-038RN
Hopkins C, Surda P, Bast F, Hettige R, Walker A, Hellings PW. Prevention of chronic rhinosinusitis. Rhinology. 2018;56(4):307–315. doi:10.4193/Rhin18.217
Tomassen P, Vandeplas G, Van Zele T, et al. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. J Allergy Clin Immunol. 2016;137(5):1449–1456.e4. doi:10.1016/j.jaci.2015.12.1324
Hastan D, Fokkens WJ, Bachert C, et al. Chronic rhinosinusitis in Europe—an underestimated disease: a GA²LEN study. Allergy. 2011;66(9):1216–1223. doi:10.1111/j.1398-9995.2011.02646.x
van der Lans RJL, Fokkens WJ, Reitsma S. Therapeutic options for chronic rhinosinusitis in NSAID-exacerbated respiratory disease patients. Front Allergy. 2021;2:735768. doi:10.3389/falgy.2021.735768
Neposlan J, Sowerby LJ, Biadsee A. Mepolizumab for the treatment of chronic rhinosinusitis with nasal polyps in adults. Expert Rev Respir Med. 2023;17(3):227–236. doi:10.1080/17476348.2023.2173291
Bachert C, Han JK, Desrosiers MY, et al. Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: a randomized, placebo-controlled trial. J Allergy Clin Immunol. 2022;149(4):1309–1317.e12. doi:10.1016/j.jaci.2021.11.019
Gliklich RE, Metson R. Effect of sinus surgery on quality of life. Otolaryngol Head Neck Surg. 1997;117(1):12–17. doi:10.1016/S0194-5998(97)70201-2
Han JK. Subclassification of chronic rhinosinusitis. Laryngoscope. 2013;123(Suppl 15):S15–S27. doi:10.1002/lary.24403
Narwani V, Torabi SJ, Kasle DA, Patel RA, Lerner MZ, Manes RP. Adverse events associated with corticosteroid-eluting sinus stents: a MAUDE database analysis. Otolaryngol Head Neck Surg. 2022;166(1):179–182. doi:10.1177/01945998211040343
Smith TL, Schlosser RJ, Mace JC, et al. Long-term outcomes of endoscopic sinus surgery in the management of adult chronic rhinosinusitis. Int Forum Allergy Rhinol. 2019;9(8):831–841. doi:10.1002/alr.22369
Hoffman V, Mortimer KM, Mulder K, Topuria I, Gliklich R, Kallman JE. Real-world evidence analysis of the impact of steroid-eluting implants on healthcare resource use among chronic rhinosinusitis patients undergoing sinus surgery. Curr Med Res Opin. 2022;38(3):375–381. doi:10.1080/03007995.2022.2026338
Lee VS, Patel P, O’Brien D, et al. Indications for absorbable steroid-eluting sinus implants: viewpoint via the Delphi method. Int Forum Allergy Rhinol. 2022;12(10):1225–1231. doi:10.1002/alr.23001
Intersect ENT. Localized steroid-releasing sinus implant (SINUVA™). Product information.
Lavigne F, Miller SK, Gould AR, Lanier BJ, Romett JL. Steroid-eluting sinus implant for in-office treatment of recurrent nasal polyposis: a prospective, multicenter study. Int Forum Allergy Rhinol. 2014;4(5):381–389. doi:10.1002/alr.21296
Shen J, Welch K, Kern R. Mometasone furoate sinus implant: a new targeted approach to treating recurrent nasal polyp disease. Expert Rev Clin Pharmacol. 2018;11(12):1163–1170. doi:10.1080/17512433.2018.1549481
Ow R, Groppo E, Clutter D, Gawlicka AK. Steroid-eluting sinus implant for in-office treatment of recurrent polyposis: a pharmacokinetic study. Int Forum Allergy Rhinol. 2014;4(10):816–822. doi:10.1002/alr.21368
Schilling AL, Cannon E, Lee SE, Wang EW, Little SR. Advances in controlled drug delivery to the sinonasal mucosa. Biomaterials. 2022;282:121430. doi:10.1016/j.biomaterials.2022.121430
Forwith KD, Han JK, Stolovitzky JP, et al. RESOLVE: bioabsorbable steroid-eluting sinus implants for in-office treatment of recurrent sinonasal polyposis after sinus surgery—6-month outcomes. Int Forum Allergy Rhinol. 2016;6(6):573–581. doi:10.1002/alr.21708
Kern RC, Stolovitzky JP, Silvers SL, et al. A phase 3 trial of mometasone furoate sinus implants for chronic sinusitis with recurrent nasal polyps. Int Forum Allergy Rhinol. 2018;8(4):471–481. doi:10.1002/alr.22056
Han JK, Forwith KD, Smith TL, et al. RESOLVE: a randomized, controlled, blinded study of bioabsorbable steroid-eluting sinus implants. Int Forum Allergy Rhinol. 2014;4(11):861–870. doi:10.1002/alr.21395
Wei CC, Kennedy DW. Mometasone implant for chronic rhinosinusitis. Med Devices (Auckl). 2012;5:75–80. doi:10.2147/MDER.S23306
Smith TL, Singh A, Luong A, et al. Randomized controlled trial of a bioabsorbable steroid-releasing implant in the frontal sinus opening. Laryngoscope. 2016;126(12):2659–2664. doi:10.1002/lary.25970
Santarelli GD, Han JK. Evaluation of the PROPEL Mini sinus implant for the treatment of frontal sinus disease. Expert Opin Drug Deliv. 2016;13(12):1789–1793. doi:10.1080/17425247.2016.1227785
Luong A, Ow RA, Singh A, et al. Safety and effectiveness of a bioabsorbable steroid-releasing implant for the paranasal sinus ostia. JAMA Otolaryngol Head Neck Surg. 2018;144(1):28–35. doi:10.1001/jamaoto.2017.2616
Han JK, Kern RC. Topical therapies for management of chronic rhinosinusitis: steroid implants. Int Forum Allergy Rhinol. 2019;9(Suppl 1):S22–S26. doi:10.1002/alr.22336
Murr AH, Smith TL, Hwang PH, et al. Safety and efficacy of a novel bioabsorbable, steroid-eluting sinus stent. Int Forum Allergy Rhinol. 2011;1(1):23–32. doi:10.1002/alr.20007
Forwith KD, Chandra RK, Yun PT, Miller SK, Jampel HD. ADVANCE: a multisite trial of bioabsorbable steroid-eluting sinus implants. Laryngoscope. 2011;121(11):2473–2480. doi:10.1002/lary.22215
Matheny KE. Bioabsorbable steroid-releasing sinus implants in the frontal and maxillary sinuses: 2-year follow-up. Allergy Rhinol (Providence). 2015;6(2):e88–e93. doi:10.2500/ar.2015.6.0110
Matheny KE, Carter KB Jr, Tseng EY, Fong KJ. Safety, feasibility, and efficacy of placement of steroid-eluting bioabsorbable sinus implants in the office setting. Int Forum Allergy Rhinol. 2014;4(10):808–815. doi:10.1002/alr.21357
Marple BF, Smith TL, Han JK, et al. Advance II: a prospective, randomized study assessing safety and efficacy of bioabsorbable steroid-releasing sinus implants. Otolaryngol Head Neck Surg. 2012;146(6):1004–1011. doi:10.1177/0194599812437499
Shah VN, Pasick LJ, Benito DA, Ghiam MK, D’Aguillo C. Complications associated with PROPEL mometasone furoate bioabsorbable drug-eluting sinus stents from 2012 to 2020. Am J Rhinol Allergy. 2022;36(2):185–190. doi:10.1177/19458924211043657
Douglas RG, Psaltis AJ, Rimmer J, et al. Phase 1 clinical study to assess the safety of a novel drug delivery system providing long-term topical steroid therapy. Int Forum Allergy Rhinol. 2019;9(4):378–387. doi:10.1002/alr.22266
DeFatta Health. PROPEL® and SINUVA™ sinus implants. Product information.
Stolovitzky JP, Kern RC, Han JK, et al. In-office placement of mometasone furoate sinus implants for recurrent nasal polyps: a pooled analysis. Am J Rhinol Allergy. 2019;33(5):545–558. doi:10.1177/1945892419853518
Article Sidebar
Download
No new data was generated or analyzed in this study. All information was obtained from previously published literature due to the narrative nature of this review.